Suchergebnisse
Katalog
Aufsätze & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- sec filing 40 Treffer
- akero therapeutics inc. 28 Treffer
- biopharmaceutical companies 20 Treffer
- pharmaceutical companies 20 Treffer
- akebia therapeutics inc. 16 Treffer
-
45 weitere Werte:
- biotechnology industries 10 Treffer
- securities 9 Treffer
- united states. securities & exchange commission 9 Treffer
- industry classification 7 Treffer
- investment and finance 6 Treffer
- anemia 4 Treffer
- anemia treatment 4 Treffer
- drugs 4 Treffer
- fda actions 4 Treffer
- hematologic diseases and conditions 4 Treffer
- hemic and lymphatic diseases and conditions 4 Treffer
- quarterly reports 4 Treffer
- therapeutics 4 Treffer
- united states. food & drug administration 4 Treffer
- business enterprises 3 Treffer
- chronic kidney failure 3 Treffer
- corporation reports 3 Treffer
- dialysis 3 Treffer
- drug therapy 3 Treffer
- government agencies offices and entities 3 Treffer
- unaudited financial statements 3 Treffer
- akebia therapeutics 2 Treffer
- biotechnology 2 Treffer
- biotechnology companies 2 Treffer
- blood diseases 2 Treffer
- chronically ill 2 Treffer
- fda 2 Treffer
- patents 2 Treffer
- pharmaceutical biotechnology industry 2 Treffer
- proteins 2 Treffer
- security holders 2 Treffer
- term loans 2 Treffer
- u.s. food and drug administration 2 Treffer
- acetic acid 1 Treffer
- adults 1 Treffer
- advertising 1 Treffer
- biological factors 1 Treffer
- blood proteins 1 Treffer
- borrowing capacity 1 Treffer
- business revenue 1 Treffer
- chemicals 1 Treffer
- chronic kidney disease 1 Treffer
- colony stimulating factors 1 Treffer
- consultants 1 Treffer
- cytokines 1 Treffer
Publikation
Sprache
Inhaltsanbieter
48 Treffer
-
In: Drug Week, 2024-03-19, S. 4597serialPeriodicalZugriff:
-
In: Drug Week, 2024-03-19, S. 4597serialPeriodicalZugriff:
-
In: Drug Week, 2024-03-19, S. 4599serialPeriodicalZugriff:
-
In: Drug Week, 2024-03-19, S. 4598serialPeriodicalZugriff:
-
Akero Therapeutics, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Dec. 29, 2023).In: Drug Week, 2024-01-19, S. 2926serialPeriodicalZugriff:
-
In: Drug Week, 2023-12-01, S. 4372serialPeriodicalZugriff:
-
In: Drug Week, 2024-01-19, S. 2927serialPeriodicalZugriff:
-
In: Drug Week, 2023-12-01, S. 4371serialPeriodicalZugriff:
-
In: Drug Week, 2023-07-14, S. 4090serialPeriodicalZugriff:
-
In: Drug Week, 2023-07-14, S. 4089serialPeriodicalZugriff:
-
In: Drug Week, 2023-07-07, S. 4415serialPeriodicalZugriff:
-
In: Drug Week, 2023-07-07, S. 4415serialPeriodicalZugriff:
-
In: Drug Week, 2023-06-02, S. 3684serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-04-05, S. 4358serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-04-09, S. 74serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-02-13, S. 269serialPeriodicalZugriff:
-
In: Pharma Business Week, 2024-01-22, S. 3841serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-12-05, S. 59serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-11-14, S. 382serialPeriodicalZugriff:
-
In: Pharma Business Week, 2023-09-04, S. 407serialPeriodicalZugriff: